“Electrocardiographic and Biochemical Adverse Effects of Meglumine Antimoniate (MA) During Treatment of Syrian Cutaneous Leishmaniasis Patients”. Journal of Pakistan Association of Dermatologists, vol. 23, no. 4, Dec. 2016, pp. 412-7, https://doi.org/10.66344/jpad.v23i4.289.